These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3089702)

  • 1. Rheohepatogram as a parameter in assessing immediate effects of propranolol on portal hypertension.
    Wu XN; Gu JK; Wang GL; Ding MM
    Chin Med J (Engl); 1986 Jan; 99(1):27-31. PubMed ID: 3089702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
    Wu XN
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of propranolol and nitroglycerin on portal pressure and the mechanism of their reducing portal pressure.
    Terada M; Notsumata K; Unoura M; Kobayashi K; Hattori N
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():254-8. PubMed ID: 2519070
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of propranolol on intrahepatic portal hypertension in the rat].
    Jirón MI; Mella JG; Mánquez P; Kauer G; Wolff C; Jabsa Z; Soto JR; Armas-Merino R
    Rev Med Chil; 1987 Mar; 115(3):189-92. PubMed ID: 3432784
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of pituitrin in hemorrhage from the esophageal veins and during surgery of patients with portal hypertension].
    Tsatsanidi KN; Novik MG; Shertsinger AG
    Vestn Khir Im I I Grek; 1970 May; 104(5):29-33. PubMed ID: 5449357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of potassium orotate on the indicators of rheohepatogram in patients with coronary arteriosclerosis].
    Gorbachev VV; Vecherskiĭ GA; Baranov LG
    Ter Arkh; 1975; 47(1):86-90. PubMed ID: 1114454
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of the calibrated Valsalva test on hepatic regional circulation in normal subjects and in patients with portal hypertension caused by intrahepatic block].
    Posteli T; Garbini GC
    Atti Soc Ital Cardiol; 1968; 2():37-9. PubMed ID: 5743871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of intravenous propranolol on portal hypertension.
    Gupta KM; Chadda S; Chadda VS; Panwar RB; Sharda DP; Mishra SN; Chaudhary A
    J Assoc Physicians India; 1984 Apr; 32(4):343-4. PubMed ID: 6746547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of portal hypertension and oesophageal varices.
    Cales P; Braillon A; Lebrec D
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1144. PubMed ID: 6414607
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
    Mazzone O; Randazzo G; Catalano D; Noè I
    Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of balloon occlusion of the inferior vena cava on indices of regional and systemic hemodynamics].
    Borisov AE; Zemlianoĭ VL; Kashchenko VA; Beliaeva EL; Letina IuV; Kuvandykov NKh
    Vestn Khir Im I I Grek; 1999; 158(4):29-34. PubMed ID: 10533219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.